Laetitia Devy

5.9k total citations · 1 hit paper
33 papers, 3.1k citations indexed

About

Laetitia Devy is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Laetitia Devy has authored 33 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cancer Research, 19 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Laetitia Devy's work include Protease and Inhibitor Mechanisms (19 papers), Angiogenesis and VEGF in Cancer (11 papers) and Peptidase Inhibition and Analysis (8 papers). Laetitia Devy is often cited by papers focused on Protease and Inhibitor Mechanisms (19 papers), Angiogenesis and VEGF in Cancer (11 papers) and Peptidase Inhibition and Analysis (8 papers). Laetitia Devy collaborates with scholars based in Belgium, France and United States. Laetitia Devy's co-authors include Agnès Noël, Jean Michel Foidart, Jean‐Michel Foidart, Karine Bonjean, Stephan Ruetz, Jeanette M. Wood, Jonathan R. Green, Vincent Castronovo, Akeila Bellahcène and Carine Munaut and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Oncogene and Clinical Cancer Research.

In The Last Decade

Laetitia Devy

33 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic Acid

2002 656 citations Jeanette M. Wood, Karine Bonjean et al. Journal of Pharmacology and Experimental Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laetitia Devy Belgium	24	1.5k	1.3k	1.0k	427	369	33	3.1k
George Vasios United States	6	3.0k 2.1×	777 0.6×	1.5k 1.5×	221 0.5×	34 0.1×	7	4.2k
Jeroen T. Buijs Netherlands	27	1.5k 1.0×	1.5k 1.1×	509 0.5×	80 0.2×	85 0.2×	52	2.9k
Sonja Loges Germany	35	2.7k 1.9×	1.9k 1.5×	1.4k 1.4×	480 1.1×	24 0.1×	98	5.0k
Evangelia Pardali Netherlands	30	2.2k 1.5×	815 0.6×	617 0.6×	171 0.4×	33 0.1×	47	3.7k
Thomas F. Zioncheck United States	28	2.1k 1.5×	550 0.4×	541 0.5×	222 0.5×	19 0.1×	38	3.5k
Nor Eddine Sounni Belgium	31	1.7k 1.2×	1.3k 1.0×	1.6k 1.6×	308 0.7×	12 0.0×	51	3.5k
David J. Shields United States	23	1.7k 1.2×	648 0.5×	634 0.6×	520 1.2×	20 0.1×	44	3.2k
Shiu‐Feng Huang Taiwan	29	1.4k 1.0×	1.2k 0.9×	596 0.6×	93 0.2×	99 0.3×	78	2.9k
Sanna-Maria Käkönen Finland	19	1.8k 1.3×	2.1k 1.6×	797 0.8×	73 0.2×	311 0.8×	41	3.7k
Eline Menu Belgium	41	2.9k 2.0×	1.4k 1.1×	998 1.0×	1.8k 4.3×	37 0.1×	131	4.3k

Countries citing papers authored by Laetitia Devy

Since Specialization

Citations

This map shows the geographic impact of Laetitia Devy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laetitia Devy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laetitia Devy more than expected).

Fields of papers citing papers by Laetitia Devy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laetitia Devy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laetitia Devy. The network helps show where Laetitia Devy may publish in the future.

Co-authorship network of co-authors of Laetitia Devy

This figure shows the co-authorship network connecting the top 25 collaborators of Laetitia Devy. A scholar is included among the top collaborators of Laetitia Devy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laetitia Devy. Laetitia Devy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ager, Eleanor I, Sergey V. Kozin, Nathaniel D. Kirkpatrick, et al.. (2015). Blockade of MMP14 Activity in Murine Breast Carcinomas: Implications for Macrophages, Vessels, and Radiotherapy. JNCI Journal of the National Cancer Institute. 107(4). 103 indexed citations

Blacher, Silvia, Laetitia Devy, Agnès Noël, & Jean-Michel Foidart. (2011). QUANTIFICATION OF ANGIOGENESIS ON THE RAT AORTIC RING ASSAY. Image Analysis & Stereology. 22(1). 43–43. 4 indexed citations

Devy, Laetitia & Daniel T. Dransfield. (2010). New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies. Biochemistry Research International. 2011. 1–11. 64 indexed citations

Devy, Laetitia, Shafaat A. Rabbani, Ian Mackie, et al.. (2007). PEGylated DX-1000: Pharmacokinetics and Antineoplastic Activity of a Specific Plasmin Inhibitor. Neoplasia. 9(11). 927–937. 28 indexed citations

Valckenborgh, Els Van, Peter I. Croucher, Hendrik De Raeve, et al.. (2004). Multifunctional role of matrix metalloproteinases in multiple myeloma: study in the 5T2mm mouse model.. VUBIR (Vrije Universiteit Brussel). 1 indexed citations

Valckenborgh, Els Van, Peter I. Croucher, Hendrik De Raeve, et al.. (2004). Multifunctional Role of Matrix Metalloproteinases in Multiple Myeloma. American Journal Of Pathology. 165(3). 869–878. 42 indexed citations

Rakic, Jean‐Marie, Catherine Maillard, Maud Jost, et al.. (2003). Role of plasminogen activator-plasmin system in tumor angiogenesis. Cellular and Molecular Life Sciences. 60(3). 463–473. 104 indexed citations

Hajitou, Amin, Christine Grignet‐Debrus, Laetitia Devy, et al.. (2003). The Antitumoral Effect of Endostatin and Angiostatin is Associated With a Down-Regulation of Vascular Endothelial Growth Factor Expression in Tumor Cells. International Journal of Gynecological Cancer. 13. 62–62. 2 indexed citations

Devy, Laetitia, Carine Munaut, Alain Colige, et al.. (2002). Matrix and serine protease expression during leukemic cell differentiation induced by aclacinomycin and all-trans-retinoic acid. Biochemical Pharmacology. 63(2). 179–189. 21 indexed citations

10.

Deroanne, Christophe, Karine Bonjean, S. Servotte, et al.. (2002). Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling. Oncogene. 21(3). 427–436. 333 indexed citations

11.

Masson, Véronique, Laetitia Devy, Christine Grignet‐Debrus, et al.. (2002). Mouse aortic ring assay: A new approach of the molecular genetics of angiogenesis. Biological Procedures Online. 4(1). 24–31. 117 indexed citations

12.

Valckenborgh, Els Van, Hendrik De Raeve, Laetitia Devy, et al.. (2002). Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo. British Journal of Cancer. 86(5). 796–802. 46 indexed citations

13.

Wood, Jeanette M., Karine Bonjean, Stephan Ruetz, et al.. (2002). Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic Acid. Journal of Pharmacology and Experimental Therapeutics. 302(3). 1055–1061. 656 indexed citations breakdown →

14.

Hajitou, Amin, Christine Grignet‐Debrus, Laetitia Devy, et al.. (2002). The antitumoral effect of endostatin and angiostatin is associated with a down‐regulation of vascular endothelial growth factor expression in tumor cells. The FASEB Journal. 16(13). 1–23. 137 indexed citations

15.

Blacher, Silvia, Laetitia Devy, Mike F. Burbridge, et al.. (2001). Improved quantification of angiogenesis in the rat aortic ring assay. Angiogenesis. 4(2). 133–142. 83 indexed citations

16.

Kebers, Florence, Jean-Marc Lewalle, Joëlle Desreux, et al.. (1998). Induction of Endothelial Cell Apoptosis by Solid Tumor Cells. Experimental Cell Research. 240(2). 197–205. 66 indexed citations

17.

Devy, Laetitia, et al.. (1997). P53 protein expression in human multidrug-resistant CEM lymphoblasts. Leukemia Research. 21(2). 147–152. 10 indexed citations

18.

Devy, Laetitia, Agnès Noël, Eugenia N. Baramova, et al.. (1997). Production and Activation of Matrix Metalloprotease-9 (MMP-9) by HL-60 Promyelocytic Leukemia Cells. Biochemical and Biophysical Research Communications. 238(3). 842–846. 25 indexed citations

19.

Jeannesson, Pierre, Rachid Lahlil, Benoı̂t Chénais, et al.. (1997). Anthracyclines as Tumor Cell Differentiating Agents: Effects on the Regulation of Erythroid Gene Expression. Leukemia & lymphoma. 26(5-6). 575–587. 31 indexed citations

20.

Morceau, Franck, Anne Aries, Rachid Lahlil, et al.. (1996). Evidence for distinct regulation processes in the aclacinomycin- and doxorubicin-mediated differentiation of human erythroleukemic cells. Biochemical Pharmacology. 51(6). 839–845. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact